Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Analysis Group

Analysis Group is listed as a large business research supplier in the Scientist.com network, with 16 sites in 6 countries.

View Analysis Group on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 16
Countries 6

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Large business

Clinical Trials

  • Clinical Research Services Determine the safety and effectiveness of medications and medical devices.
  • Clinical Trial Design Develop study-related protocols, case report forms (CRFs) and database tools for records management.
  • Nutritional Trials and Studies Conduct clinical trials to test the efficacy and safety of food and dietary products.
  • Prospective Explorative Studies Conduct a prospective exploratory study to assess the safety and efficacy of a test drug during clinical trials.

Data Science/Bioinformatics

  • Biostatistical Design Use statistics to ensure appropriate pre-clinical and clinical study design.
  • RWE/HEOR Data Science and Modeling A process that helps make sense of your clinical data
  • RWE/HEOR Drug/Therapy Discontinuation Analysis An analysis to understand patient behavior. Are the drugs taken on time, do the patients discontinue use, and if so how long after starting, etc.
  • RWE/HEOR Machine Learning/AI Complex analytical approaches to find patterns and make predictions in RWE/HEOR projects

HEOR

  • Burden of Illness/Disease Strategy and study related to assessing the impact (economic, non-economic) of disease on health outcomes in a country, region, community, patient, or health system.
  • Clinical Outcome Assessments (Non-Patient Reported) Measure a patient's symptoms, mental state and level of disease condition-related impact on daily life.
  • Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
  • Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
  • Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
  • Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
Show all 14 in HEOR 8 more
  • Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
  • Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
  • HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
  • Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
  • Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
  • Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
  • Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
  • Therapy Switch Insight into the reasoning of patients switching treatments and the outcomes of the switch.
Show all 46 services 32 more

Medical Communications

  • HEOR/Value Publications Writing and submission of manuscripts and abstracts focusing on Health Economics and Outcomes Research (HEOR) data, which demonstrate the economic and value proposition of a therapy.
  • Medical Publications Make clear and accurate presentations of scientific and technical data.
  • Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.

Medical/Commercial

  • Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.
  • Life Cycle Assessment (LCA) Analyze the lifecycles of the products and services with regard to their environmental impacts.

Old Category HEOR, RWE, Market Access

  • Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
  • Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.

Real World Evidence & Data

  • Clinical Phenotype Data Obtain phenotypic data and observations on patients such as the clinical manifestation of the disease, clinical and behavioral parameters, symptoms, and laboratory test results.
  • Data Asset Validation Tools for validating that patient data and source has been accurately recorded.
  • Data Merging Tools for combining various data sets into a single data set. Includes data consolidation.
  • Predictive Analytics Variety of statistical techniques from data mining, predictive modeling, and machine learning, that analyze current and historical facts to make predictions about future or otherwise unknown events.
  • Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
  • Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
Show all 11 in Real World Evidence & Data 5 more
  • Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
  • Retrospective Exploratory Studies Retrospective exploratory studies
  • RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
  • RWE/HEOR/Market Access Safety Surveillance Monitor safety of treatment and determine methods to identify adverse events early
  • Secondary Real World Evidence Analyze clinical trial data.

Regulatory Affairs

  • Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
  • Patient Risk Management Identify, contain, and manage risks related to patient safety.
  • Post-authorization Safety Studies Research efforts conducted after a drug has been approved for market to monitor its safety profile in the general population. These studies aim to identify, characterize, or quantify potential adverse effects...
  • Safety Signals Early indication that a new or unknown adverse event occurred that may be caused by treatment and investigation is needed to determine a causal relationship. Can be investigated through spontaneous reports, studies...

Scientific Data Services

  • Bayesian Statistics Extract information from data sets that are subject to error or noise to see unobserved possibilities.

Other services

  • Observational Research Gain valuable insights into the association between a drug treatment and its outcomes such as long-term effectiveness and safety.

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United States Boston, Chicago, Dallas, Denver, Los Angeles, Menlo Park and 3 more 10 sites
  • Canada Montreal, Toronto 2 sites
  • Belgium Bruxelles 1 site
  • China Chaoyang, Beijing 1 site
  • France Paris 1 site

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

Analysis Group provides economic, financial, and business strategy consulting to law firms, corporations, and government agencies.

Website
www.analysisgroup.com

Source: Scientist.com supplier network, written by the supplier

Get the Analysis Group report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Analysis Group on Scientist.com

For prices, more details, or to contact Analysis Group, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.